These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31023063)

  • 1. A Comparison of Resource Utilization in the Management of Anticholinergic Delirium Between Physostigmine and Nonantidote Therapy.
    Boley SP; Stellpflug SJ
    Ann Pharmacother; 2019 Oct; 53(10):1026-1032. PubMed ID: 31023063
    [No Abstract]   [Full Text] [Related]  

  • 2. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center.
    Boley SP; Olives TD; Bangh SA; Fahrner S; Cole JB
    Clin Toxicol (Phila); 2019 Jan; 57(1):50-55. PubMed ID: 29956570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of physostigmine: a 10-year retrospective review.
    Arens AM; Shah K; Al-Abri S; Olson KR; Kearney T
    Clin Toxicol (Phila); 2018 Feb; 56(2):101-107. PubMed ID: 28703024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome.
    Wang GS; Baker K; Ng P; Janis GC; Leonard J; Mistry RD; Heard K
    Clin Toxicol (Phila); 2021 Aug; 59(8):698-704. PubMed ID: 33295809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine for the management of anticholinergic delirium.
    Chiew AL; Holford AG; Chan BSH; Isoardi KZ
    Clin Toxicol (Phila); 2024 Feb; 62(2):82-87. PubMed ID: 38465631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged Antimuscarinic Delirium in a Child Due to Benztropine Exposure Treated With Multiple Doses of Physostigmine.
    Thornton SL; Farnaes L; Minns A
    Pediatr Emerg Care; 2016 Apr; 32(4):243-5. PubMed ID: 26383155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine reversal of delirium from second generation antipsychotic exposure: a retrospective cohort study from a regional poison center.
    Arens AM; Sheikh Said H; Driver BE; Cole JB
    Clin Toxicol (Phila); 2024 Jul; 62(7):463-467. PubMed ID: 38984853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
    Hail SL; Obafemi A; Kleinschmidt KC
    Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Effects of Physostigmine.
    Arens AM; Kearney T
    J Med Toxicol; 2019 Jul; 15(3):184-191. PubMed ID: 30747326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
    Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
    J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
    Burns MJ; Linden CH; Graudins A; Brown RM; Fletcher KE
    Ann Emerg Med; 2000 Apr; 35(4):374-81. PubMed ID: 10736125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of diagnostic physostigmine administration to emergency department patients.
    Schneir AB; Offerman SR; Ly BT; Davis JM; Baldwin RT; Williams SR; Clark RF
    Ann Emerg Med; 2003 Jul; 42(1):14-9. PubMed ID: 12827117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity.
    Watkins JW; Schwarz ES; Arroyo-Plasencia AM; Mullins ME;
    J Med Toxicol; 2015 Jun; 11(2):179-84. PubMed ID: 25510306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological management of anticholinergic delirium - theory, evidence and practice.
    Dawson AH; Buckley NA
    Br J Clin Pharmacol; 2016 Mar; 81(3):516-24. PubMed ID: 26589572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
    Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
    Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic Medication Use and Transition to Delirium in Critically Ill Patients: A Prospective Cohort Study.
    Wolters AE; Zaal IJ; Veldhuijzen DS; Cremer OL; Devlin JW; van Dijk D; Slooter AJ
    Crit Care Med; 2015 Sep; 43(9):1846-52. PubMed ID: 26010688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physostigmine: is there a role for this antidote in pediatric poisonings?
    Frascogna N
    Curr Opin Pediatr; 2007 Apr; 19(2):201-5. PubMed ID: 17496766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physostigmine versus diazepines for anticholinergic poisoning.
    Oakley P
    Ann Emerg Med; 2001 Feb; 37(2):239-41. PubMed ID: 11174251
    [No Abstract]   [Full Text] [Related]  

  • 19. Timing and frequency of physostigmine redosing for antimuscarinic toxicity.
    Rosenbaum C; Bird SB
    J Med Toxicol; 2010 Dec; 6(4):386-92. PubMed ID: 20405266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events from physostigmine: An observational study.
    Nguyen TT; Armengol C; Wilhoite G; Cumpston KL; Wills BK
    Am J Emerg Med; 2018 Jan; 36(1):141-142. PubMed ID: 28716594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.